Currently, there are 2.10B common shares owned by the public and among those 1.97B shares have been available to trade.
The company’s stock has a 5-day price change of 6.90% and 48.18% over the past three months. PLTR shares are trading 86.84% year to date (YTD), with the 12-month market performance up to 107.64% higher. It has a 12-month low price of $13.68 and touched a high of $31.50 over the same period. PLTR has an average intraday trading volume of 44.73 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 15.46%, 21.04%, and 45.07% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Palantir Technologies Inc (NYSE: PLTR) shares accounts for 41.03% of the company’s 2.10B shares outstanding.
It has a market capitalization of $71.84B and a beta (3y monthly) value of 2.70. The stock’s trailing 12-month PE ratio is 188.82, while the earnings-per-share (ttm) stands at $0.17. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.45% over the week and 5.72% over the month.
Earnings per share for the fiscal year are expected to increase by 41.94%, and 19.15% over the next financial year.
Looking at the support for the PLTR, a number of firms have released research notes about the stock. Monness Crespi & Hardt stated their Sell rating for the stock in a research note on August 06, 2024, with the firm’s price target at $20-$18. Mizuho coverage for the Palantir Technologies Inc (PLTR) stock in a research note released on July 16, 2024 offered a Underperform rating with a price target of $22. Monness Crespi & Hardt was of a view on June 21, 2024 that the stock is Sell, while Argus gave the stock Buy rating on June 17, 2024, issuing a price target of $29. Monness Crespi & Hardt on their part issued Neutral rating on April 26, 2024.
